UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 27, 2010
SILICON LABORATORIES INC.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
000-29823 |
|
74-2793174 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
of Incorporation) |
|
|
|
Identification No.) |
400 West Cesar Chavez, Austin, TX |
|
78701 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (512) 416-8500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition
On October 27, 2010, Silicon Laboratories Inc. (Silicon Laboratories) issued a press release describing its results of operations for its fiscal quarter ended October 2, 2010. A copy of the press release is attached as Exhibit 99 to this report.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
99 Press Release of Silicon Laboratories Inc. dated October 27, 2010.
Use of Non-GAAP Financial Information
From time to time, Silicon Laboratories provides certain non-GAAP financial measures as additional information relating to its operating results. The non-GAAP financial measurements provided in the press release furnished herewith do not replace the presentation of Silicon Laboratories GAAP financial results. These additional measurements merely provide supplemental information to assist investors in analyzing Silicon Laboratories financial position and results of operations; however, these measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Silicon Laboratories has chosen to provide this information to investors because it believes that such supplemental information enables them to perform meaningful comparisons of past, present and future operating results, and as a means to highlight the results of core ongoing operations.
Pursuant to the requirements of Regulation G, we have provided in the press release furnished with this report a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
The information in this report, including the exhibit hereto, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. The information contained therein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Silicon Laboratories, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SILICON LABORATORIES INC. |
|
|
|
|
|
|
October 27, 2010 |
|
/s/ Paul V. Walsh, Jr. |
Date |
|
Paul V. Walsh, Jr. Vice President of Finance (Principal Accounting Officer) |
Exhibit 99
SILICON LABORATORIES REPORTS THIRD QUARTER RESULTS
AUSTIN, Texas Oct. 27, 2010 Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported revenue of $120.2 million for the third quarter, and better than anticipated earnings per share of $0.40.
Financial Highlights
Third quarter revenue of $120.2 million represented a five percent decrease from the same period in 2009. Third quarter GAAP gross margin was 65.5 percent. R&D investment for the third quarter was nearly flat sequentially at $30.8 million. SG&A expense declined to $28.6 million. GAAP operating income was 16.1 percent. The GAAP tax rate was six percent, resulting in fully diluted earnings per share of $0.40.
The following non-GAAP results exclude the impact of stock compensation expense and other one-time items. Non-GAAP gross margin for the quarter was down slightly as expected to 65.8 percent, but still above the companys target model. Non-GAAP operating expenses declined to $49.4 million. Specifically, R&D was about flat at $26.4 million and SG&A decreased to $23.0 million. Non-GAAP operating income totaled 24.7 percent of revenue. Non-GAAP diluted earnings per share were at the high end of revised guidance at $0.53. The reconciling charges are set forth in the financial measures table included below.
Share repurchases during the quarter totaled $40 million, bringing the year-to-date total to $140 million. The company ended the quarter with $365 million in cash, cash equivalents and investments due to continued healthy cash flow from operations.
Business Summary
The revenue decline in the quarter was due in part to demand weakness and inventory
misalignment for the companys products shipping into consumer-oriented applications. The Access business was down as anticipated. The Broadcast business experienced a market-related slowdown in the companys Consumer Audio products as well as the expected declines in handsets. The Broad-based business was also impacted by end market weakness, particularly Embedded Mixed-Signal products, which were down sequentially, while Timing products enjoyed another record quarter.
The company continued to secure strategic design wins across its growth businesses, including new wins in wireless, timing, isolation, human interface, microcontroller, consumer audio and video products, providing strong evidence of the companys ability to return to revenue growth as the end markets recover. New Class D amplifier and human interface products announced during the quarter also represent expansions of the companys portfolio in key end markets. Research and development hiring and investment continued, with new products in development at a record high.
While this retreat in revenue is uncharacteristic, we believe the fourth quarter represents a trough, and the composition of the business that will emerge in 2011 will be even more growth oriented, said Necip Sayiner, President and CEO of Silicon Laboratories. Were very optimistic about progress in our emerging video product line and continue to view our Broad-based business as a strategic growth engine in 2011 and beyond.
The company guided revenue for the fourth quarter in the range of $105 to $111 million.
Webcast and Conference Call
A conference call discussing the results will follow this press release today at 7:30 a.m. central time. An audio webcast will be available simultaneously on Silicon Laboratories website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 1 (800) 642-1687 or +1 (706) 645-9291 (international). Replays will be available through November 10, 2010.
About Silicon Laboratories Inc.
Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories, please visit www.silabs.com.
Forward Looking Statements
This press release contains forward-looking statements based on Silicon Laboratories current expectations. The words believe, estimate, expect, intend, anticipate, plan, project, will and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly, difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; inventory-related risks; risks associated with acquisitions; difficulties managing international activities; difficulties managing our manufacturers and subcontractors; risks that Silicon Laboratories may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel; risks associated with divestitures; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Laboratories business and results of operations to risks of natural disasters, epidemics, war and political unrest; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Silicon Laboratories Inc., Shannon Pleasant, (512) 464 9254, shannon.pleasant@silabs.com
Silicon Laboratories Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
|
|
Three Months Ended |
|
Nine Months Ended |
|
||||||||
|
|
October 2, |
|
October 3, |
|
October 2, |
|
October 3, |
|
||||
Revenues |
|
$ |
120,154 |
|
$ |
125,913 |
|
$ |
381,450 |
|
$ |
313,830 |
|
Cost of revenues |
|
41,484 |
|
44,878 |
|
128,297 |
|
117,336 |
|
||||
Gross margin |
|
78,670 |
|
81,035 |
|
253,153 |
|
196,494 |
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
30,769 |
|
25,904 |
|
91,200 |
|
77,841 |
|
||||
Selling, general and administrative |
|
28,556 |
|
28,592 |
|
86,296 |
|
78,221 |
|
||||
Operating expenses |
|
59,325 |
|
54,496 |
|
177,496 |
|
156,062 |
|
||||
Operating income |
|
19,345 |
|
26,539 |
|
75,657 |
|
40,432 |
|
||||
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||
Interest income |
|
540 |
|
546 |
|
1,839 |
|
2,083 |
|
||||
Interest expense |
|
(21 |
) |
(51 |
) |
(66 |
) |
(154 |
) |
||||
Other income (expense), net |
|
(394 |
) |
8 |
|
(1,277 |
) |
298 |
|
||||
Income before income taxes |
|
19,470 |
|
27,042 |
|
76,153 |
|
42,659 |
|
||||
Provision for income taxes |
|
1,237 |
|
4,603 |
|
15,794 |
|
9,819 |
|
||||
Net income |
|
$ |
18,233 |
|
$ |
22,439 |
|
$ |
60,359 |
|
$ |
32,840 |
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings per share: |
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
0.41 |
|
$ |
0.50 |
|
$ |
1.34 |
|
$ |
0.73 |
|
Diluted |
|
$ |
0.40 |
|
$ |
0.47 |
|
$ |
1.28 |
|
$ |
0.71 |
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
||||
Basic |
|
44,341 |
|
45,170 |
|
45,182 |
|
44,814 |
|
||||
Diluted |
|
46,009 |
|
47,322 |
|
47,103 |
|
46,127 |
|
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
|
|
Three Months Ended |
|
|||||||||||
Non-GAAP Income |
|
GAAP |
|
GAAP |
|
Stock |
|
Non-GAAP |
|
Non-GAAP |
|
|||
Revenues |
|
$ |
120,154 |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|||
Gross margin |
|
78,670 |
|
65.5 |
% |
$ |
368 |
|
$ |
79,038 |
|
65.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Research and development |
|
30,769 |
|
25.6 |
% |
4,371 |
|
26,398 |
|
22.0 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||
Selling, general and administrative |
|
28,556 |
|
23.8 |
% |
5,591 |
|
22,965 |
|
19.1 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||
Operating expenses |
|
59,325 |
|
49.4 |
% |
9,962 |
|
49,363 |
|
41.1 |
% |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||
Operating income |
|
19,345 |
|
16.1 |
% |
10,330 |
|
29,675 |
|
24.7 |
% |
|||
|
|
Three Months Ended |
|
||||||||||
Non-GAAP Diluted |
|
GAAP |
|
Stock |
|
Acquisition |
|
Non-GAAP |
|
||||
Net income |
|
$ |
18,233 |
|
$ |
9,009 |
|
$ |
(2,713 |
) |
$ |
24,529 |
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted shares outstanding |
|
46,009 |
|
|
|
|
|
46,009 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Diluted earnings per share |
|
$ |
0.40 |
|
|
|
|
|
$ |
0.53 |
|
||
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
|
|
October 2, |
|
January 2, |
|
||
Assets |
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
107,651 |
|
$ |
195,737 |
|
Short-term investments |
|
238,341 |
|
214,486 |
|
||
Accounts receivable, net of allowance for doubtful accounts of $771 at October 2, 2010 and $567 at January 2, 2010 |
|
63,801 |
|
56,128 |
|
||
Inventories |
|
38,140 |
|
31,512 |
|
||
Deferred income taxes |
|
10,318 |
|
7,620 |
|
||
Prepaid expenses and other current assets |
|
29,960 |
|
18,515 |
|
||
Total current assets |
|
488,211 |
|
523,998 |
|
||
Long-term investments |
|
19,313 |
|
24,676 |
|
||
Property and equipment, net |
|
25,910 |
|
27,785 |
|
||
Goodwill |
|
109,222 |
|
105,109 |
|
||
Other intangible assets, net |
|
46,156 |
|
41,886 |
|
||
Other assets, net |
|
21,328 |
|
19,384 |
|
||
Total assets |
|
$ |
710,140 |
|
$ |
742,838 |
|
|
|
|
|
|
|
||
Liabilities and Stockholders Equity |
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
||
Accounts payable |
|
$ |
26,837 |
|
$ |
28,759 |
|
Accrued expenses |
|
27,751 |
|
25,399 |
|
||
Deferred income on shipments to distributors |
|
33,193 |
|
28,470 |
|
||
Income taxes |
|
298 |
|
6,011 |
|
||
Total current liabilities |
|
88,079 |
|
88,639 |
|
||
Long-term obligations and other liabilities |
|
21,661 |
|
24,403 |
|
||
Total liabilities |
|
109,740 |
|
113,042 |
|
||
Commitments and contingencies |
|
|
|
|
|
||
Stockholders equity: |
|
|
|
|
|
||
Preferred stock$0.0001 par value; 10,000 shares authorized; no shares issued and outstanding |
|
|
|
|
|
||
Common stock$0.0001 par value; 250,000 shares authorized; 43,720 and 45,772 shares issued and outstanding at October 2, 2010 and January 2, 2010, respectively |
|
4 |
|
5 |
|
||
Additional paid-in capital |
|
37,175 |
|
128,262 |
|
||
Retained earnings |
|
566,244 |
|
505,885 |
|
||
Accumulated other comprehensive loss |
|
(3,023 |
) |
(4,356 |
) |
||
Total stockholders equity |
|
600,400 |
|
629,796 |
|
||
Total liabilities and stockholders equity |
|
$ |
710,140 |
|
$ |
742,838 |
|
# # #